Giuseppe Giaccone
机构: Professor of Medicine, Weill Cornell University
每年引用次数
引用次数
引用: 85,795
H-指数: 143
I10-指数 : 624
出版物: 1,224
Phase II study of the histone deacetylase inhibitor belinostat in thymic malignancies
G. Giaccone , A. Rajan , C. Carter , R. Kelly
Journal of Clinical Oncology 27 7589 -7589
9
2009
SATURN: A double-blind, randomized, phase III study of maintenance erlotinib versus placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC
F. Cappuzzo , T. Ciuleanu , L. Stelmakh , S. Cicenas
Journal of Clinical Oncology 27 8001 -8001
120
2009
Efficacy and safety of PF-00299804 (PF299) in patients (pt) with advanced NSCLC after failure of at least one prior chemotherapy regimen and prior treatment with erlotinib (E): A two-arm, phase II trial
P. A. Janne , K. Reckamp , M. Koczywas , J. A. Engelman
Journal of Clinical Oncology 27 ( 15_suppl) 8063 -8063
40
2009
Phase I study of vandetanib (V) and bevacizumab (B) combination therapy evaluating the VEGF and EGF signal transduction pathways in adults with solid tumors and NHL
M. Gutierrez , A. J. Murgo , D. Allen , I. Turkbey
Journal of Clinical Oncology 27 3522 -3522
1
2009
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
V.C.G. Tjan-Heijnen , P.E. Postmus , A. Ardizzoni , Ch. Manegold
Annals of Oncology 12 ( 10) 1359 -1368
119
2001
A phase I–II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients
G. Giaccone , E.F. Smit , J.P. van Meerbeeck , T. Splinter
Annals of Oncology 11 ( 1) 109 -112
53
2000
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer
A.H. Honkoop , E. van der Wall , N. Feller , G.-J. Schuurhuis
Annals of Oncology 8 ( 10) 957 -962
16
1997
5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients
H.H.J. Backus , D.F. Dukers , C.J. van Groeningen , W. Vos
Annals of Oncology 12 ( 2) 209 -216
61
2001
Caelyx™ in malignant mesothelioma: A phase II EORTC study
P. Baas , J. van Meerbeeck , H. Groen , H. Schouwink
Annals of Oncology 11 ( 6) 697 -700
49
2000
Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors
B. Van Triest , H.M. Pinedo , G. Giaccone , G.J. Peters
Annals of Oncology 11 ( 4) 385 -391
150
2000
Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment
M. Janas , L. R. Bailey , K. Schmidt , N. Bindslev
Journal of Clinical Oncology 22 7024 -7024
4
2004
Evaluation of epidermal growth factor receptor (EGFR) as a predictive marker in patients with non-small-cell lung cancer (NSCLC) receiving first-line gefitinib combined with platinum-based chemotherapy
L. R. Bailey , M. Janas , K. Schmidt , N. Bindslev
Journal of Clinical Oncology 22 7013 -7013
37
2004
A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC
J. P. Van Meerbeeck , C. Manegold , R. Gaafar , R. J. van Klaveren
Journal of Clinical Oncology 22 7021 -7021
27
2004
MDICT Task Force: Methodology for the Development of Innovative Cancer Therapies
E.A. Eisenhauer , G. Giaccone
Annals of Oncology 18
2007
Taille d’échantillon dans les essais thérapeutiques en oncologie
N. Meyer , C. Legrand , G. Giaccone
Revue D Epidemiologie Et De Sante Publique 59
2011
Characterization of a Topoisomerase II Gene Rearrangement in a Human Small-Cell Lung Cancer Cell Line
M. Binaschi , G. Giaccone , A. F. Gazdar , P. De Isabella
Journal of the National Cancer Institute 84 ( 22) 1710 -1716
15
1992
A phase I combination study of olaparib (AZD2281; KU-0059436) and cisplatin (C) plus gemcitabine (G) in adults with solid tumors.
G Giaccone , A Rajan , RJ Kelly , M Gutierrez
Journal of Clinical Oncology 28 3027 -3027
29
2010
258 Biology and treatment of thymoma
G. Giaccone
Ejc Supplements 8 ( 7) 84
2010
Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy
S.V. Alarcon , M. Mollapour , M.-J. Lee , S. Tsutsumi
Current Molecular Medicine 12 ( 9) 1125 -1141
35
2012
1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial
G. Giaccone , E. Felip , M. Cobo , R. Garcia Campelo
Annals of Oncology 31 ( 9)
1
2020